Vor Biopharma Inc at Barclays Global Healthcare Conference Transcript
Good afternoon, and welcome to day two of the Barclays Global Healthcare Conference. My name is Carter Gould, senior biopharma analyst here at Barclays. It's my pleasure to welcome Vor Biopharma to the stage. Joining us from the company is Robert Ang, President and CEO; as well as Nathan Jorgensen, CFO. Robert, Nathan, welcome.
Thanks for having us here.
It seems like just a year ago, we were here. And, in fact, that's exactly what it was, but you've made a lot of progress. We've seen data.
We have.
So I guess maybe to start things off, let's talk about that initial set of engraftment data and maybe just help set up the rest of the discussion with your takeaways from the data as it emerged.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
